Paper · 2021

Treatment of Resistant and Ultra Resistant Schizophrenia.

Antonija Medić, Dora Herceg, Miroslav Herceg

PubMed, 33(Suppl 4), 1099–1105 · Published 1 January 2021

View at the publisherCite this paper

In brief

“Treatment of Resistant and Ultra Resistant Schizophrenia.” is a 2021 paper by Antonija Medić and 2 co-authors, published in PubMed. OpenAlex counts 5 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
5
Most cited in
2022 (2)
Field-weighted impact
0.55
Authors
3

Abstract

Schizophrenia is a psychiatric disease which affects one percent of population. It is most common in young adults. It is primarily treated with typical and atypical antipsychotics. Resistant schizophrenia is a condition diagnosed after no response is noticed to two different antipsychotics of which one is atypical. The treatment has to be undertaken with adequate… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Medić, A., Herceg, D., & Herceg, M. (2021). Treatment of Resistant and Ultra Resistant Schizophrenia. PubMed, 33(Suppl 4), 1099–1105. https://pubmed.ncbi.nlm.nih.gov/35354175

MLA 9

Medić, Antonija, et al. “Treatment of Resistant and Ultra Resistant Schizophrenia.” PubMed, vol. 33, no. Suppl 4, 2021, pp. 1099–1105. https://pubmed.ncbi.nlm.nih.gov/35354175.

Chicago

Medić, Antonija, Dora Herceg, and Miroslav Herceg. 2021. “Treatment of Resistant and Ultra Resistant Schizophrenia.” PubMed 33 (Suppl 4): 1099–1105. https://pubmed.ncbi.nlm.nih.gov/35354175.

Harvard

Medić, A., Herceg, D. and Herceg, M. (2021) ‘Treatment of Resistant and Ultra Resistant Schizophrenia.’, PubMed, 33(Suppl 4), pp. 1099–1105. Available at: https://pubmed.ncbi.nlm.nih.gov/35354175.

IEEE

A. Medić, D. Herceg, and M. Herceg, “Treatment of Resistant and Ultra Resistant Schizophrenia.,” PubMed, vol. 33, no. Suppl 4, pp. 1099–1105, 2021.

BibTeX

@article{medic2021treatment,
  title     = {{Treatment of Resistant and Ultra Resistant Schizophrenia.}},
  author    = {Medić, Antonija and Herceg, Dora and Herceg, Miroslav},
  journal   = {PubMed},
  year      = {2021},
  volume    = {33},
  number    = {Suppl 4},
  pages     = {1099--1105},
  url       = {https://pubmed.ncbi.nlm.nih.gov/35354175}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202222
202311
202411
202611

Its field-weighted citation impact is 0.55: it has been cited 0.55 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • treatment-resistant schizophrenia
  • clozapine
  • antipsychotic drugs
  • atypical antipsychotics
  • typical antipsychotics
  • agranulocytosis
  • antipsychotic polypharmacy
  • electroconvulsive therapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Medić, A., Herceg, D., & Herceg, M. (2021). Treatment of Resistant and Ultra Resistant Schizophrenia. PubMed, 33(Suppl 4), 1099–1105. https://pubmed.ncbi.nlm.nih.gov/35354175

How many times has this paper been cited?

5 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Antonija Medić, Dora Herceg, Miroslav Herceg.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.